Signal from the log
Lucis
20 M$ · Series A · France · Diagnostics
Société parisienne de suivi préventif qui cartographie cent dix biomarqueurs sanguins et en tire des recommandations. Elle revendique dix mille utilisateurs, dont 80 % refont un test, et trois biomarqueurs améliorés en six mois pour les trois quarts d'entre eux. La série A arrive quatre mois après un amorçage de 8 M$.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 20 M$
- Stage
- Series A
- Country
- France
- Sector
- Diagnostics
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Singular , with General Catalyst , Y Combinator
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.